Comparative Assessment of the Anticoagulant Activity of Rivaroxaban and Dabigatran in Patients With Nonvalvular Atrial Fibrillation: A Noninterventional Study.

Medicine (Baltimore) · 2016 · PMC4998746 · PMID 27057830

Europe PMC DOI

hedged sentence

0.0930

closest p · 1.9× alpha

0.0930

boldest claim

The sentences

did not reach statistical significanceP = 0.093so close (0.05 < p ≤ 0.1)

Patients on dabigatran exhibited statistically significant lower aggregation values compared to rivaroxaban group ( P = 0.045), but aggregation decrease in the dabigatran group did not reach statistical significance as compared to controls ( P = 0.093).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.